Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 24 (1) , 421-431
Abstract
The objective of this study is to estimate the cost-effectiveness of KTE-X19 versus standard of care (SoC) in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients from a U...Keywords
This publication has 32 references indexed in Scilit:
- Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyJournal of Clinical Oncology, 2014
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and ModalityJournal of Clinical Oncology, 2014
- Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 studyAnnals of Oncology, 2013
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell LymphomaNew England Journal of Medicine, 2013
- Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Unresponsive Mantle Cell Lymphoma: A Cohort Analysis from the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2013
- Cure Models as a Useful Statistical Tool for Analyzing SurvivalClinical Cancer Research, 2012
- Estimating the Cure Fraction in Population-Based Cancer Studies by Using Finite Mixture ModelsJournal of the Royal Statistical Society Series C: Applied Statistics, 2009
- A Class of Semiparametric Mixture Cure Survival Models With Dependent CensoringJournal of the American Statistical Association, 2009
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Cure fraction estimation from the mixture cure models for grouped survival dataStatistics in Medicine, 2004